M. Bjursten

Serum interleukin-1 receptor antagonist is an early indicator of colitis onset in Galphai2-deficient mice.

E. Hultgren Hörnquist, M. Berglund, O. Hultgren, 2006, World journal of gastroenterology.

Transfer of Colitis by G&agr;i2‐deficient T Lymphocytes: Impact of Subpopulations and Tissue Origin

R. Willén, M. Bjursten, E. Hörnquist, 2005, Inflammatory bowel diseases.

Aberrant T‐cell ontogeny and defective thymocyte and colonic T‐cell chemotactic migration in colitis‐prone Gαi2‐deficient mice

R. Willén, K. Elgbratt, P. Bland, 2007, Immunology.

Enhanced pro-inflammatory cytokine production in Galphai2-deficient mice on colitis prone and colitis resistant 129Sv genetic backgrounds.

E. Hultgren Hörnquist, O. Hultgren, M. Bjursten, 2004, Cellular immunology.

Long‐term treatment with anti‐α4 integrin antibodies aggravates colitis in Gαi2‐deficient mice

R. Willén, P. Bland, M. Bjursten, 2005 .

Dietary Antigen‐Specific T‐Cell Responses: Switch from an Interleukin‐10‐Dominated Response in Normal Mice to a T‐Helper 1 Cytokine Profile in Gαi2‐Deficient Mice prior to Colitis

E. Hultgren Hörnquist, M. Bjursten, 2005, Scandinavian journal of immunology.

Long-term treatment with anti-alpha 4 integrin antibodies aggravates colitis in G alpha i2-deficient mice.

R. Willén, P. Bland, M. Bjursten, 2005, European journal of immunology.